Major changes in lung cancer over the last ten years in France: The KBP-CPHG studies

Lung Cancer

Volumn 81, Issue 1, 2013, Pages 32-38

  Locher, Chrystèle ^a   Debieuvre, Didier ^b   Coëtmeur, Daniel ^c   Goupil, François ^d   Molinier, Olivier ^d   Collon, Thierry ^e   Dayen, Charles ^f   Le Treut, Jacques ^g   Asselain, Bernard ^h   Martin, Francis ⁱ   Blanchon, François ^a   Grivaux, Michel ^a  

^a General Hospital Center   (France)

^b Respiratory Medicine Department   (France)

^c Yves Le Foll Hospital   (France)

^d GENERAL HOSPITAL   (France)

^e Cardiology Department   (France)

^f Respiratory Medicine Department   (France)

^g Pays d'Aix Hospital   (France)

^h INSTITUT CURIE   (France)

ⁱ Respiratory Medicine Department   (France)

Author keywords

Adenocarcinoma; Epidemiology; France; General; Hospitals; Lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; COMPARATIVE STUDY; CONTROLLED STUDY; EMOTIONAL STRESS; FEMALE; FRANCE; GENERAL HOSPITAL; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCCUPATIONAL EXPOSURE; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SEX RATIO; SMOKING; STANDARDIZATION; UNIVERSITY HOSPITAL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; FRANCE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84878974012     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.03.001     Document Type: Article

References (37)

1. Jemal A., Bray F., Center M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. INCa. [The cancer situation in France in 2010]. Collections rapports & syntheses. Boulogne-Billancourt; November 2010 [in French].
3. InVS, INCa, Francim, HÔpitaux de Lyon, CépiDc, Inserm. Projection of incidence and cancer mortality in France in 2010. Technical Report; April 2010 [in French].
4. Molinié F, Velten M, Remontet L, Bercelli P, et le réseau FRANCIM. The progression of lung cancer in France (1978-2000). Rev Mal Resp 2006;23:127-34 [in French].
5. Institut national du cancer (INCa). Actions against smoking. Date last accessed: July 18, 2012. http://lesdonnees.e-cancer.fr/les-fiches-de-synthese/3-facteurs-risque/41-tabac/69-actions-lutte-contre-tabagisme.html.
6. Zalcman G., Bergot E. Lechapt. Update on nonsmall cell lung cancer. Eur Respir Rev 2010, 19:173-185.
7. Pérol M., Odier L., Arpin D. The maintenance strategies in first line treatment of advanced non-small cell lung cancers. La lettre du cancérologue 2010, 13:102-111. [in French].
8. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., et al. Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
9. Rusch V.W., Crowley J., Giroux D.J., Goldstraw P., Im J.G., Tsuboi M., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:603-612.
10. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM Stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:706-714.
11. Blanchon F., Grivaux M., Collon T., Zureik M., Barbieux H., Bénichou-Flurin M., et al. Epidemiologic of primary bronchial carcinoma management in the general French hospital centers. Rev Mal Respir 2002, 19:727-734. [in French].
12. Blanchon F., Grivaux M., Asselain B., Lebas F.X., Orlando J.P., Piquet J., et al. 4-Year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol 2006, 7:829-836.
13. Grivaux M., Locher C., Bombaron P., Collon T., Coëtmeur D., Dayen C., et al. Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010. Rev Pneumol Clin 2010, 66:375-382. [in French].
14. Montesinos J., Bare M., Dalmau E., Saigi E., Villace P., Nogue M., et al. The changing pattern of non-small cell lung cancer between the 90 and 2000 decades. Open Respir Med J 2011, 5:24-30.
15. Kawaguchi T., Takada M., Kubo A., Matsumura A., Fukai S., Tamura A., et al. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan. J Thorac Oncol 2010, 5:1011-1017.
16. Quoix E., Zalcman G., Oster J.P., Westeel V., Pichon E., Lavolé A., et al. Intergroupe Francophone de Cancérologie Thoracique. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 2011, 378:1079-1088.
17. Corre R, Chouaid C, Barlesi F, Le Caer H, Dansin E, Vergnenegre A, Fournel P, GFPC. Study ESOGIA-GFPC 08-02: Phase III, randomized, multicenter trial involving subjects over age 70 with stage IV non-small cell lung cancer and comparing a "classical" strategy of treatment allocation (dual-agent therapy based on carboplatin or monotherapy with docetaxel alone), based on performance status and age, with an "optimized" strategy allocating the same treatments according to a simplified geriatric screening scale, plus a more thorough geriatric evaluation if necessary. J Clin Oncol 29:2011 [suppl; abstr TPS219].
18. Locher C., Pourel N., Marin B., Vergnenègre A. et le GFPC. A phase II study of weekly cisplatine plus oral vinorelbine with concomitant radiotherapy in non-dependent elderly patients with localized inoperable non small cell lung carcinoma (Essai GFPC 08-06, Raccosa). Rev Mal Respir 2011, 28:58-65. [in French].
19. International Agency for Research on Cancer (IARC). Globocan 2008. Lung cancer incidence and mortality worldwide in 2008. Summary. Date last accessed: July 19, 2012. http://globocan.iarc.fr/factsheet.asp.
20. Jiang X., de Groh M., Liu S., Liang H., Morrison H. Rising incidence of adenocarcinoma of the lung in Canada. Lung Cancer 2012, 78:16-22.
21. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse P., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56:159-175.
22. Institut de veille sanitaire (InVS). Special issue - world no tobacco day, 31 May 2010. Bull Epidemiol Hebd 2010;19-20:209-24 [in French].
23. Tyczynski J.E., Bray F., Parkin D.M. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol 2003, 4:45-55.
24. Fitting J.W. Lung cancer among non-smokers. Int J Tuberc Lung Dis 2012, 16:429.
25. Scagliotti G.V., Longo M., Novello S. Nonsmall cell lung cancer in never smokers. Curr Opin Oncol 2009, 21:99-104.
26. Samet J.M., Avila-Tang E., Boffetta P., Hannan L.M., Olivo-Marston S., Thun M.J., et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res 2009, 15:5626-5645.
27. Brenner D.R., McLaughlin J.R., Hung R.J. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One 2011, 6:e17479.
28. Turner M.C., Chen Y., Krewski D., Calle E.E., Thun M.J. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007, 176:285-290.
29. Gould M.K., Maclean C.C., Kuschner W.G., Rydzak C.E., Owens D.K. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001, 285:914-924.
30. Bourguet P. Group de Travail SOR.Standards, options and recommendations for the use of positron emission tomography with [18F]-FDG (PET-FDG) in cancerology (integral connection). Bull Cancer 2003, 90(S5-17). [in French].
31. Legmann M. Atlas of medical demography in France situation on 1 January 2010. CNOM - Paris 2010 [in French].
32. Wynder E.L., Muscat J.E. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect 1995, 103:143-148.
33. Hoffmann D., Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997, 50:307-364.
34. Djordjevic M.V., Fan J., Ferguson S., Hoffmann D. Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes. Carcinogenesis 1995, 16:2015-2021.
35. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6(2):244-285.
36. Loo P.S., Thomas S.C., Nicolson M.C., Fyfe M.N., Kerr K.M. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol 2010, 5(4):442-447.
37. Nicholson A.G., Gonzalez D., Shah P., Pynegar M.J., Deshmukh M., Rice A., et al. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. J Thorac Oncol 2010, 5(4):436-441.